Singapore-based private equity firm Quadria Capital is set to invest in India’s Maxivision Eye Hospital, according to a report by The Economic Times. The deal is reportedly worth around $155 million and would give Quadria a majority stake in the company.
Maxivision Eye Hospital is one of the leading eye care chains in India, with over 100 hospitals and clinics across the country. The company provides a wide range of eye care services, including ophthalmology, optometry, and otolarynology.
Quadria Capital is a leading private equity firm with over $4 billion of assets under management. The firm invests in growth-oriented businesses in the healthcare sector, with a focus on Asia.
The investment in Maxivision Eye Hospital is a sign of Quadria’s confidence in the Indian healthcare sector. The sector is growing rapidly, driven by rising incomes and increasing demand for quality healthcare.
The investment is also a vote of confidence in Maxivision Eye Hospital’s management team. The company has a strong track record of growth and profitability.
The deal is still subject to regulatory approval, but if it is successful, it would be a major boost for Maxivision Eye Hospital. The investment would allow the company to expand its operations and reach new patients.
Here are some additional details about the investment:
- The deal is reportedly worth around $155 million.
- The investment would be funded by Quadria Capital’s latest fund, Quadria Capital Fund II.
- The deal is still subject to regulatory approval.
- If the deal is successful, it would be a major boost for Maxivision Eye Hospital.
Singapore Private Equity News Singapore
